Navigating the Treatment Landscape for Multiple Myeloma


Journal of Clinical Pathways spoke with Natalie S Callander, MD, department of hematology and oncology, University of Wisconsin Cancer Center, about her presentation at the latest NCCN Congress on Hematologic Malignancies regarding individualized treatment for patients with relapsed or refractory multiple myeloma.

To read the podcast transcript, click here.